Astera Labs, Inc. Common Stock (ALAB) P/E Ratio History
Historical price-to-earnings valuation from 2025 to 2026
Loading P/E history...
ALAB Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of May 8, 2026, Astera Labs, Inc. Common Stock (ALAB) trades at a price-to-earnings ratio of 160.4x, with a stock price of $195.65 and trailing twelve-month earnings per share of $1.48.
The current P/E is roughly in line with its 5-year average of 163.1x. Over the past five years, ALAB's P/E has ranged from a low of 74.1x to a high of 267.6x, placing the current valuation at the 40th percentile of its historical range.
Compared to the Technology sector median P/E of 27.7x, ALAB trades at a 479% premium to its sector peers. The sector includes 359 companies with P/E ratios ranging from 0.0x to 184.2x.
Relative to the broader market, ALAB commands a significant premium over the S&P 500 median P/E of 25.1x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our ALAB DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
ALAB P/E vs Peers
P/E ratio compared to closely matched public peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $139B | 52.1 | - | +401%Best | |
| $9B | 21.9Lowest | 1.31 | +31% | |
| $5.1T | 43.2 | 0.45Best | +67% | |
| $666B | 154.1 | 29.84 | +165% | |
| $2.0T | 86.5 | 1.73 | +288% | |
| $77B | 123.6 | 4.19 | -65% |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
ALAB Historical P/E Data (2025–2026)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Date | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2026 Q1 | $109.60 | $1.48 | 74.1x | -55% | |
| FY2025 Q4 | Wed Dec 31 2025 00:00:00 GM | $166.36 | $1.22 | 136.4x | -16% |
| FY2025 Q3 | $195.80 | $1.11 | 176.4x | +8% | |
| FY2025 Q2 | Mon Jun 30 2025 00:00:00 GM | $90.42 | $0.56 | 161.0x | -1% |
| FY2025 Q1 | Mon Mar 31 2025 00:00:00 GM | $59.67 | $0.22 | 267.6x | +64% |
Average P/E for displayed period: 163.1x
Full ALAB Stock Analysis
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
See ALAB's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ALAB Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare ALAB vs NVDA
Side-by-side business, growth, and profitability comparison vs NVIDIA Corporation.
Start ComparisonALAB — Frequently Asked Questions
Quick answers to the most common questions about buying ALAB stock.
Is ALAB stock overvalued or undervalued?
ALAB trades at 160.4x P/E, near its 5-year average of 163.1x. The 40th percentile ranking places valuation within normal historical bounds.
How does ALAB's valuation compare to peers?
Astera Labs, Inc. Common Stock P/E of 160.4x compares to sector median of 27.7x. The premium reflects expected growth above peers.
What is ALAB's PEG ratio?
ALAB PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 2025-2026.